ea0049oc2.2 | Diabetes Prediction and Complications | ECE2017
Shalimova Anna
, Bilovol Oleksandr
, Bobronnikova Lesya
The aim: To evaluate effectiveness of complex therapy in patients with comorbidity of type 2 diabetes (DM2) and essential hypertension (EH) depending on genetic polymorphism peroxisome proliferator-activating receptor-γ2 (PPARγ2). Before and after 3 months of treatment we examined 145 patients with EH stage II, grade and DM2 moderate, subcompensated aged 4560 years: group 1 (71 patients) received standart therapy (telmisartan, indapamide, metformin, gliclazide,...